The neuroprotective effect of overexpression of calbindin-D(28k) in an animal model of Parkinson's disease (Q44563974)

4 December 2017

The neuroprotective effect of overexpression of calbindin-D(28k) in an animal model of Parkinson's disease (English)

1 reference

4 December 2017

1 reference

1 reference

Hong-Hua Yuan

1

1 reference

4 December 2017

Ren-Jin Chen

2

1 reference

4 December 2017

Yu-Hua Zhu

3

1 reference

4 December 2017

Chang-Ling Peng

4

1 reference

4 December 2017

Xiao-Rong Zhu

5

1 reference

4 December 2017

25 August 2012

1 reference

4 December 2017

Molecular Neurobiology

1 reference

4 December 2017

47

1 reference

4 December 2017

117-122

1 reference

4 December 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-012-8332-3

4 December 2017

0 references

cites work

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Calcium-binding proteins in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Don't get too excited: mechanisms of glutamate-mediated Purkinje cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

In vitro enzyme activation with calbindin‐D28k, the vitamin D‐dependent 28 kDa calcium binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

The neurotoxin MPTP increases calbindin-D28k levels in mouse midbrain dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Calbindin-D28K prevents drug-induced dopaminergic neuronal death by inhibiting caspase and calpain activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

First Parkinson gene therapy trial launches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8332-3

Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22923348

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Protein measurement with the Folin phenol reagent

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22923348

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12035-012-8332-3

1 reference

4 December 2017

1 reference